Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol/Gillette Vaniqa To Be Launched In September For Facial Hair Removal

Executive Summary

Bristol-Myers Squibb is collecting quality of life data to document the psychosocial benefits of the prescription facial hair removal cream Vaniqa.

You may also be interested in...



Women First Vaniqa Focus Is PCOS; Bristol Broad Cosmetic Use Vanquished

Women First HealthCare will pursue managed care reimbursement for Vaniqa by positioning the facial hair removal agent as a treatment for hirsutism associated with polycystic ovary syndrome

Women First Vaniqa Focus Is PCOS; Bristol Broad Cosmetic Use Vanquished

Women First HealthCare will pursue managed care reimbursement for Vaniqa by positioning the facial hair removal agent as a treatment for hirsutism associated with polycystic ovary syndrome

FDA Accepts Drug Quality Of Life Claims From Secondary Endpoints - Bristol

FDA sometimes allows quality of life claims for drugs based on secondary endpoints in clinical trials, Bristol-Myers Squibb Health Economics Policy & External Relations Group Director Joseph Jackson, PhD, told a Drug Information Association meeting March 12 in Washington, D.C.

Related Content

UsernamePublicRestriction

Register

PS036461

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel